We studied a new method of treatment of amyotrophic lateral sclerosis with autologous mesenchymal stem cells. Autologous mesenchymal stem cells were injected intravenously (intact cells) or via lumbar puncture (cells committed to neuronal differentiation). Evaluation of the results of cell therapy after 12-month follow-up revealed slowing down of the disease progression in 10 patients in comparison with the control group consisting of 15 patients. The cell therapy was safe for the patients.
Similar content being viewed by others
References
S. M. Kosmacheva, N. N. Danilkovich, A. V. Shchepen’, et al., Bull. Exp. Biol. Med., 156, No. 4, 560–565 (2014).
A. V. Shakhbazau, N. V. Petyovka, S. M. Kosmacheva, M. P. Potapnev, et al., Bull. Exp. Biol. Med., 150, No. 4, 547–550 (2011).
S. H.Appel, J. I. Engelhardt, J. S. Henkel, et al., Neurology, 71, No. 17, 1326–1334 (2008).
I. Badayan and M. E. Gudkowicz, Amyotroph. Lateral Scler., 9, No. 6, 6321–322 (2008).
B. R. Brooks, R. G. Miller, M. Swash, and T. L. Munsat, Amyotroph. Lateral Scler., 1, No. 5, 6321–299 (2000).
J. M. Cedarbaum and N. Stambler, J. Neurol. Sci., 152, Suppl. 1, S1-S9 (1997).
E. Dantuma, S. Merchant, and K. Sugaya, Stem Cell Res. Ther., 1, No. 5, 37 (2010).
H. Deda, M.C. Inci, A. E. Kurekci, et al., Cytotherapy, 11, No. 1, 18–25 (2009).
M. Dominici, K. Le Blanc, I. Mueller, et al., Cytotherapy, 8, No. 4, 315–317 (2006).
D. A. Karnofsky and J. H. Burchenal, Evaluation of Chemotherapeutic Agents, Ed. C. M. MacLeod, New York (1949), P. 196.
D. Karussis, C. Karageorgiou, A. Vaknin-Dembinsky, et al., Arch. Neurol., 67, No. 10, 1187–1194 (2010).
X. Long, M. Olszewski, W. Huang, and M. Kletzel, Stem Cells Dev., 14, No. 2, 65–69 (2005).
L. Mazzini, I. Ferrero, and V. Luparello, Exp. Neurol., 223, No. 1, 229–237 (2010).
L. Mazzini, I. Ferrero, K. Mareschi, et al., J. Neurol. Sci., 265, Nos. 1–2, 78–83 (2008).
L. Mazzini, K. Mareschi, I. Ferrero, et al., Cytotherapy, 14, No. 1, 56–60 (2012).
R. G.Miller, J. D. Mitchell, M. Lyon, and D. H. Moore, Cochrane Database Syst. Rev., No. 1. CD001447 (2007).
Motor Neuron Disease. Biology and Management, Eds. P. N. Leigh, M. Swash, London (1995).
R. R. Sharma, K. Pollock, A. Hubel, and D. McKenna, Transfusion, 54, No. 5, 1418–1437 (2014).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Kletochnye Tekhnologii v Biologii i Meditstine, No. 2, pp. 130–136, April, 2015
Rights and permissions
About this article
Cite this article
Rushkevich, Y.N., Kosmacheva, S.M., Zabrodets, G.V. et al. The Use of Autologous Mesenchymal Stem Cells for Cell Therapy of Patients with Amyotrophic Lateral Sclerosis in Belarus. Bull Exp Biol Med 159, 576–581 (2015). https://doi.org/10.1007/s10517-015-3017-3
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-015-3017-3